Correlation Between ATyr Pharma and Trevi Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATyr Pharma and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATyr Pharma and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATyr Pharma and Trevi Therapeutics, you can compare the effects of market volatilities on ATyr Pharma and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATyr Pharma with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATyr Pharma and Trevi Therapeutics.

Diversification Opportunities for ATyr Pharma and Trevi Therapeutics

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between ATyr and Trevi is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding ATyr Pharma and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and ATyr Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATyr Pharma are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of ATyr Pharma i.e., ATyr Pharma and Trevi Therapeutics go up and down completely randomly.

Pair Corralation between ATyr Pharma and Trevi Therapeutics

If you would invest  295.00  in Trevi Therapeutics on September 4, 2024 and sell it today you would lose (9.00) from holding Trevi Therapeutics or give up 3.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy0.0%
ValuesDaily Returns

ATyr Pharma  vs.  Trevi Therapeutics

 Performance 
       Timeline  
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Trevi Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Trevi Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Trevi Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

ATyr Pharma and Trevi Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATyr Pharma and Trevi Therapeutics

The main advantage of trading using opposite ATyr Pharma and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATyr Pharma position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.
The idea behind ATyr Pharma and Trevi Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA